Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer

Cancer Detection and Prevention
Marileila Varella-GarciaWilbur A Franklin

Abstract

Survival rates for lung cancer are low because patients have disseminated disease at diagnosis; therefore tests for early diagnosis are highly desirable. This pilot study investigated occurrence of chromosomal aneusomy in sputum from a 33 case-control cohort matched on age, gender, and date of sample collection. Subjects had chronic obstructive pulmonary disease and > or = 30 pack-years of tobacco use, and aneusomy was tested using a multi-target DNA FISH assay (LAVysion, Abbott/Vysis). In specimens collected within 12 months of lung cancer diagnosis, abnormality was more frequent among the 18 cases (41%) than the 17 controls (6%; P = 0.04). Aneusomy had no significant association with cytologic atypia, which might indicate that molecular and morphological changes could be independent markers of tumorigenesis. Combining both tests, abnormality was found in 83% of the cases and 20% of the controls (P = 0.0004) suggesting that FISH may improve the sensitivity of cytologic atypia as a predictor of lung cancer.

References

Apr 10, 1997·Nature·C LengauerB Vogelstein
Jun 1, 1997·Chest·C F Mountain, C M Dresler
Oct 23, 1997·Chest·T NarukeH Nakayama
Jul 13, 2001·American Journal of Clinical Pathology·L BubendorfP Dalquen
Mar 15, 2002·Seminars in Oncology·Wilbur A FranklinPaul A Bunn
Oct 4, 2002·Oncogene·Binaifer R Balsara, Joseph R Testa
Oct 9, 2002·Current Medicinal Chemistry·C GridelliA Rossi
Oct 2, 2003·International Journal of Cancer. Journal International Du Cancer·Sabine Zöchbauer-MüllerAdi F Gazdar

❮ Previous
Next ❯

Citations

May 4, 2010·Analytical Chemistry·Jian ZhangJoseph R Lakowicz
May 27, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ruth L KatzMargaret R Spitz
Jan 6, 2006·The Cancer Journal·Lodovico Balducci
Feb 23, 2010·Current Opinion in Pulmonary Medicine·Fabien Maldonado, James R Jett
Mar 25, 2010·Cancer Prevention Research·Marileila Varella-GarciaWilbur A Franklin
Mar 25, 2010·Cancer Prevention Research·Sheila A Prindiville, Thomas Ried
Jun 30, 2007·American Journal of Respiratory and Critical Care Medicine·Marileila Varella-GarciaWilbur A Franklin
Nov 9, 2007·American Journal of Respiratory and Critical Care Medicine·Steinn JonssonWilbur A Franklin
Oct 24, 2008·American Journal of Respiratory and Critical Care Medicine·York E Miller
Dec 17, 2009·American Journal of Respiratory and Critical Care Medicine·Jesse S VossOtis B Rickman
Mar 4, 2005·American Journal of Clinical Pathology·Lukas BubendorfMichael Tamm
Apr 28, 2012·Journal of Cancer Research and Clinical Oncology·Yi-Zhen LiuMing-Rong Wang
Dec 7, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jun ShenFeng Jiang
Mar 5, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jun Qian, Pierre P Massion
Sep 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai YendamuriRuth L Katz
Nov 3, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Joanna Chorostowska-Wynimko, Adam Szpechcinski
Sep 12, 2006·Chest·Dani S Zander
Sep 26, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chang-Min ChoiSang-Do Lee
Jul 21, 2007·Human Pathology·Kevin C Halling, Benjamin R Kipp
Nov 9, 2006·Cancer·Katharina GlatzLukas Bubendorf
Mar 21, 2013·Diagnostic Cytopathology·Jullyana S S QuintansAlexandre Sherlley C Onofre
Aug 29, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eeva KettunenSisko Anttila
Jun 22, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anna E BarónMarileila Varella-Garcia
Aug 27, 2015·Biomarker Insights·Jian SuFeng Jiang
Dec 1, 2010·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·M Krkovic, M L Costa
Aug 28, 2019·Cancer Biomarkers : Section a of Disease Markers·Chhavi GuptaFeng Jiang
Jul 6, 2016·Journal of Breath Research·Sarah A HayesViive M Howell
Jan 6, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul A Bunn
Jun 13, 2012·Cancer Prevention Research·Mohamed HassaneinPierre P Massion
Mar 25, 2010·Cancer Prevention Research·Brigitte N GompertsSteven M Dubinett
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·María J PajaresLuis M Montuenga
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ruiyun LiFeng Jiang
Jan 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lingxiao XingFeng Jiang
Mar 7, 2021·Diagnostics·Qixin LengFeng Jiang
Jul 12, 2011·The Journal of Physical Chemistry. C, Nanomaterials and Interfaces·Jian ZhangJoseph R Lakowicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.